Angiotensin converting enzyme inhibition in heart failure: Clinical trials and clinical practice

Cardiovascular Drugs and Therapy

Volumn 16, Issue 1, 2002, Pages 67-74

  Squire, Iain B ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Ace inhibitors; Heart failure

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CLINICAL PRACTICE; CLINICAL TRIAL; COUGHING; DRUG EFFICACY; ENZYME INHIBITION; HEART FAILURE; HUMAN; HYPOTENSION; KIDNEY DYSFUNCTION; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLINICAL TRIALS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0036270923     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015375717044     Document Type: Review

References (54)

1. Left ventricular systolic dysfunction in 75-year-old men and women. A population based study
2. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
4. The effect of carvedilol on-top-of ACE on major cardiac events in patients with severe heart failure
5. The effect of carvedilol on-top-of ACE on outcome in patients with LV dysfunction after acute MI
6. The effect of digoxin on mortality and morbidity in patients with heart failure
7. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
8. Effects of enalapril on mortality in severe congestive heart failure
9. Effects of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure
10. Acomparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of congestive heart failure
11. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction and myocardial infarction
12. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular fractions
13. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
14. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
15. The burden of cardiovascular diseases mortality in Europe. Task force of the European society of cardiology on cardiovascular mortality and morbidity statistics in Europe
16. Trends in hospitalisation for heart failure in Scotland 1980-1990
17. The health care cost of heart failure in Sweden
18. Trends in hospitalisation and mortality for heart failure in Spain 1980-1993
19. Hospital admissions and deaths due to congestive heart failure in New Zealand 1988-1991
20. Increase for hospital admission rates for heart failure in the Netherlands 1980-1993
21. Hospitalisation of patients with heart failure: National discharge survey 1985-1995
22. The natural history of heart failure: The Framingham study
23. Congestive heart failure in the community: A study of all incident cases in Olmsted County, Minnesota in 1991
24. Trends in hospitalisation for heart failure in Scotland 1990-1996
25. Prevalence of heart failure in high risk groups
26. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalised for heart failure
27. Perindopril for elderly people with chronic heart failure: The PEP-CHF trial
28. Guidelines for the diagnosis and treatment of heart failure
29. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on evaluation and management of chronic heart failure)
30. Is the dose used the dose tested?
31. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical centre: 1990-1995
32. Self reported difference between cardiologists and heart failure specialists in the management of chronic heart failure
33. Prevalence, aetiology and management of heart failure in general practice
34. European survey of primary care physician perceptions on heart failure diagnosis and management (EURO-HF)
35. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?
36. Comparative effects of low doses and high doses of the angiotensin converting enzyme inhibitor lisinopril on morbidity and mortality in chronic heart failure
37. Angiotensin converting enzyme inhibitor prescribing patterns in patients with heart failure
38. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial-the losartan heart failure survival trial
39. Determinants of the blood pressure response to the first dose of ACE inhibitor in mild to moderate congestive heart failure
40. Post marketing surveillance of enalapril. I: Results of prescription event monitoring
41. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus; results from the ATLAS trial
42. Elimination of early rehospitalisation in a randomised, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population
43. Differences in first-dose response to angiotensin converting enzyme inhibition in congestive heart failure: A placebo-controlled study
44. Differing early blood pressure and rennin angiotensin system responses to the first dose of angiotensin converting enzyme inhibitors in congestive heart failure
45. First dose response to angiotensin enzyme converting enzyme inhibition in congestive cardiac failure: A Malaysian experience
46. First-dosehypotension after angiotensin converting enzyme (ACE) inhibitors in chronic heart failure: A comparison of enalapril and perindopril
47. Further evidence that chronic perindopril treatment maintains neurohormonal suppression but does not lower blood pressure in chronic cardiac failure
48. Parallel realities of guidelines and practice
49. Improving aspirin prophylaxis after myocardial infarction in primary care: Collaboration in multipractice audit between primary care audit group and health authority
50. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: A randomised controlled study
51. The "Improvement of Heart Failure" initiative to increase awareness and improve the management of heart failure in Europe